GKSL Fined ₹6.6 Lakhs by NSE & BSE for Delayed Financial Results
Gujarat Kidney And Superspeciality Limited (GKSL) has been fined ₹6,60,800 (₹3.3 Lakhs per exchange) by NSE and BSE for not submitting financial results for the quarter ended September 30, 2025, on time. The company received the notices on March 17, 2026, and stated no operational impact.
The company explicitly stated that there is no impact on its financial, operational, or other activities due to the fines.
The company has been fined by stock exchanges for non-compliance with listing regulations regarding financial results submission.
Gujarat Kidney And Superspeciality Limited (GKSL) has received notices from the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) for non-compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The non-compliance pertains to the non-submission of financial results for the quarter ended September 30, 2025, within the prescribed period.
As a consequence, both NSE and BSE have imposed a fine of ₹3,30,400 (basic fine plus GST) on the company. The notices were received on March 17, 2026, at 7:12 p.m. from NSE and at 6:48 p.m. from BSE. The company stated that there is no impact on its financial, operational, or other activities due to the levy of these fines.
GKSL will place the notices before the Board of Directors for their comments and to decide on the further course of action. The company has been formerly known as Gujarat Kidney And Superspeciality Private Limited and previously as Vihaan Medicare Private Limited.
What to do with a filing like this
Gujarat Kidney And Super Speciality Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Kidney And Super Speciality Limited. Read the original for the full detail.